Overview
Andriani Charpidou practices in Athens, Greece. Charpidou is highly rated in 3 conditions, according to our data. Their top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Adenocarcinoma, and EGFR Positive Lung Cancer.
Their clinical research consists of co-authoring 55 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Lung CancerCharpidou isDistinguished. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)Charpidou isDistinguished. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Advanced
- Lung AdenocarcinomaCharpidou isAdvanced. Learn about Lung Adenocarcinoma.
- Experienced
- Brain TumorCharpidou isExperienced. Learn about Brain Tumor.
- EGFR Positive Lung CancerCharpidou isExperienced. Learn about EGFR Positive Lung Cancer.
- Lung MetastasesCharpidou isExperienced. Learn about Lung Metastases.
- PneumoniaCharpidou isExperienced. Learn about Pneumonia.
- Small Cell Lung Cancer (SCLC)Charpidou isExperienced. Learn about Small Cell Lung Cancer (SCLC).
- SVC ObstructionCharpidou isExperienced. Learn about SVC Obstruction.